or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Representative Michael C. Burgess's Public Statements on Drugs

Full Name: Michael C. Burgess
Office: U.S. House (TX) - District 26, Republican
First Elected: 11/05/2002
Last Elected: 11/06/2012
Next Election: 2014
Gender: Male
Family: Wife: Laura; 3 Children
Birth Date: 12/23/1950
Birth Place: Rochester, MN
Home City: Lewisville, TX
Religion: Episcopalian
Date Title Location
May 30, 2012 Food and Drug Administration Reform Act of 2012 Washington, DC
Feb. 21, 2012 Burgess Presses FDA on Drug Shortages, FDA Responds By Allowing Importation of Replacement Drug Washington, DC
Nov. 17, 2011 The Hill - A QuietRevolution -- and a Helping Hand Unknown
Nov. 7, 2011 Letter to Margaret Hamburg, Food and Drug Administration (FDA) Commissioner Washington, DC
Sept. 26, 2011 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Impact of Medical Device and Drug Regulation on Innovation, Jobs and Patients: A Local Perspective. Washington, DC
July 7, 2011 Health Subcommittee Examines FDA Regulatory Process Washington, DC
April 22, 2010 Health Care Washington, DC
March 16, 2010 Health Care Reform Washington, DC
Feb. 25, 2010 Health Care Summit Washington, DC
Feb. 2, 2010 Televise Health Care Negotiations Washington, DC
Dec. 8, 2009 Hearing Of The Subcommittee On Health Of The House Committee On Energy And Commerce - "Prescription Drug Prices: Are Prices Rising Too Fast?" Washington, DC
Oct. 20, 2009 North Texas Daily: Letter To The Editor: Congressman Supports Kidney Bill Unknown
Oct. 14, 2009 Health Care Reform Washington, DC
June 11, 2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition Washington, DC
April 21, 2009 Health Care in America Washington, DC
April 1, 2009 Family Smoking Prevention and Tobacco Control Act Washington, DC
May 15, 2008 Subcommittee on Health Hearing re: Discussion Draft of the ‘Food and Drug Administration Globalization Act' Legislation: Device and Cosmetic Safety Provisions Washington, DC
May 1, 2008 Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation Washington, DC
April 30, 2008 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Heparin Disaster: Chinese Counterfeits and American Failures Washington, DC
April 22, 2008 Panel I of a Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Food and Drug Administration's Foreign Drug Inspection Program Washington, DC
Feb. 6, 2008 The Health Care Reform that America Needs Washington, DC
Feb. 6, 2008 Health Care Washington, DC
Dec. 11, 2007 The Growing and Disturbing Trend of Food and Consumer Product Safety Recalls Washington, DC
Nov. 8, 2007 Food Safety and Product Recall Washington, DC
Nov. 1, 2007 Hearing of the Subcommittee on Oversight & Investigations of the House Committee on Energy and Commerce - FDA Foreign Drug Inspection Program Washington, DC
Oct. 30, 2007 Safety Recalls Washington, DC
Oct. 22, 2007 Health Care in America Washington, DC
Oct. 11, 2007 Hearing of the House Energy and Commerce Committee's Oversight and Investigations Subcommittee, Panel I - Security of the Nation's Food Supply? Washington, DC
Oct. 10, 2007 Health Care in America Washington, DC
Sept. 26, 2007 Hearing of the Subcommittee on Health of the House Committee on Energy and Commerce - H.R. 3610, The Food and Drug Import Safety Act Washington, DC
Aug. 2, 2007 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Washington, DC
July 17, 2007 Health Care Washington, DC
July 11, 2007 Food And Drug Administration AMendments Act Of 2007 Washington, DC
July 10, 2007 Revision To Allocation For House Committees Washington, DC
June 21, 2007 Drug Safety/PDUFA/MDUFA Mark-Up Washington, DC
June 19, 2007 Drug Safety/PDUFA/MDUFA Mark-Up Washington, DC
May 22, 2007 Health Care Washington, DC
May 9, 2007 Assessing the Safety of Our Nation's Drug Supply Washington, DC
April 17, 2007 Prescription Drug User Fee Act Hearing Washington, DC
March 22, 2007 The Adequacy of the FDA to Assure the Safety of Drug Supply—Part 2 Washington, DC
Feb. 13, 2007 The Adequacy of the FDA to Assure the Safety of Drug Supply Washington, DC
Jan. 12, 2007 Medicare Prescription Drug Price Negotiation Act of 2007 Washington, DC
Jan. 8, 2007 Why the Government SHOULD NOT Negotiate Drug Prices Washington, DC
Sept. 20, 2006 Addressing The Medicare Part D Doughnut Hole Washington, DC
May 10, 2006 Encouraging All Eligible Medicare Beneficiaries to Review Available Options to Determine Whether Enrollment in a Medicare Prescription Drug Plan Best Washington, DC
May 1, 2006 The Burgess Bulletin - May 2006 Unknown
March 30, 2006 Health Care Washington, DC
March 29, 2006 Medicare's Prescription Drug Benefit Washington, DC
Nov. 15, 2005 Medicare Prescription Part D Drug Plan Washington, DC
Oct. 18, 2005 Medicare Part D Washington, DC
Back to top